Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration
about
Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
P2860
Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration
description
im April 2017 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2017
@uk
name
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@en
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@nl
type
label
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@en
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@nl
prefLabel
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@en
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@nl
P2093
P2860
P356
P1476
Geographic Differences in Temp ...... Drugs: The InC3 Collaboration
@en
P2093
Andrea L Cox
Andrew Lloyd
Arthur Y Kim
Georg M Lauer
Gregory Dore
Jason Grebely
Judith A Hahn
Julie Bruneau
Kimberly Page
Lisa Maher
P2860
P304
P356
10.1093/CID/CIW869
P407
P50
P577
2017-04-01T00:00:00Z